Cullinan Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
12,400
-13,300
| -52% | -$1.43M | 0.09% | 118 |
|
|
2025
Q1 | $2.59M | Sell |
25,700
-1,700
| -6% | -$171K | 0.18% | 96 |
|
|
2024
Q4 | $2.45M | Sell |
27,400
-1,600
| -6% | -$143K | 0.16% | 102 |
|
|
2024
Q3 | $2.56M | Buy |
29,000
+500
| +2% | +$44.1K | 0.14% | 107 |
|
|
2024
Q2 | $2.19M | Hold |
28,500
| – | – | 0.12% | 110 |
|
|
2024
Q1 | $1.95M | Hold |
28,500
| – | – | 0.11% | 119 |
|
|
2023
Q4 | $1.65M | Hold |
28,500
| – | – | 0.09% | 122 |
|
|
2023
Q3 | $1.5M | Hold |
28,500
| – | – | 0.09% | 130 |
|
|
2023
Q2 | $1.54M | Buy |
28,500
+9,500
| +50% | +$514K | 0.08% | 136 |
|
|
2023
Q1 | $951K | Sell |
19,000
-1,400
| -7% | -$70K | 0.06% | 160 |
|
|
2022
Q4 | $944K | Hold |
20,400
| – | – | 0.05% | 167 |
|
|
2022
Q3 | $790K | Hold |
20,400
| – | – | 0.05% | 155 |
|
|
2022
Q2 | $760K | Hold |
20,400
| – | – | 0.05% | 151 |
|
|
2022
Q1 | $904K | Hold |
20,400
| – | – | 0.05% | 148 |
|
|
2021
Q4 | $867K | Buy |
20,400
+15,000
| +278% | +$638K | 0.04% | 147 |
|
|
2021
Q3 | $234K | Hold |
5,400
| – | – | 0.01% | 216 |
|
|
2021
Q2 | $231K | Hold |
5,400
| – | – | 0.01% | 210 |
|
|
2021
Q1 | $209K | Buy |
+5,400
| New | +$209K | 0.01% | 205 |
|
|
2014
Q2 | – | Sell |
-41,965
| Closed | -$567K | – | 86 |
|
|
2014
Q1 | $567K | Hold |
41,965
| – | – | 0.06% | 82 |
|
|
2013
Q4 | $504K | Hold |
41,965
| – | – | 0.06% | 82 |
|
|
2013
Q3 | $492K | Hold |
41,965
| – | – | 0.07% | 83 |
|
|
2013
Q2 | $389K | Buy |
+41,965
| New | +$389K | 0.05% | 84 |
|